Identification of N-phenyl-3-methoxy-4-pyridinones as orally bioavailable H3 receptor antagonists and β-amyloid aggregation inhibitors for the treatment of Alzheimer’s disease-Reference-Cited by-同舟云学术

Identification of N-phenyl-3-methoxy-4-pyridinones as orally bioavailable H3 receptor antagonists and β-amyloid aggregation inhibitors for the treatment of Alzheimer’s disease

Published:2021-02 Issue: Volume:212 Page:113096
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhang Minkui,Tang Li,Jiang Liu,Wei Jun,Hu Yongzhou,Sheng Rong^ORCID

Funder

Natural Science Foundation of Zhejiang Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference35 articles.

1. World Alzheimer Report 2018: the State of the Art of Dementia Research: New Frontiers;Wortmann,2018

2. Therapeutics of Alzheimer’s disease: past, present and future;Anand;Neuropharmacology,2014

3. Alzheimer’s disease;Ballard;Lancet,2011

4. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline;Raina;Ann. Intern. Med.,2008

5. A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer’s disease;Takeda;Int. J. Geriatr. Psychiatr.,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of plasma Aβ1-40 for Alzheimer’s disease;American Journal of Translational Research;2024

2. In vitro and in vivo biological evaluation of newly synthesized multi-target 20(R)-panaxadiol derivatives for treating Alzheimer's disease;European Journal of Medicinal Chemistry;2022-12

3. A single-molecule with multiple investigations: Synthesis, characterization, computational methods, inhibitory activity against Alzheimer's disease, toxicity, and ADME studies;Computers in Biology and Medicine;2022-07

4. Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation;Bioorganic & Medicinal Chemistry;2021-11